A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Public ClinicalTrials.gov record NCT00048568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate Versus Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Study identification
- NCT ID
- NCT00048568
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 1,250 participants
Conditions and interventions
Conditions
Interventions
- Abatacept Drug
- Methotrexate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Sep 30, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Dec 4, 2011
2002 – 2009
United States locations
- U.S. sites
- 48
- U.S. states
- 24
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Huntsville | Alabama | — | — |
| Local Institution | Mobile | Alabama | — | — |
| Local Institution | Phoenix | Arizona | — | — |
| Local Institution | Scottsdale | Arizona | — | — |
| Local Institution | Corona | California | — | — |
| Local Institution | Irvine | California | — | — |
| Local Institution | La Jolla | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Rancho Mirage | California | — | — |
| Local Institution | Aurora | Colorado | — | — |
| Local Institution | Colorado Springs | Colorado | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Hamden | Connecticut | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Fort Lauderdale | Florida | — | — |
| Local Institution | Gainsville | Florida | — | — |
| Local Institution | Palm Harbor | Florida | — | — |
| Local Institution | Sarasota | Florida | — | — |
| Local Institution | St. Petersburg | Florida | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Rockford | Illinois | — | — |
| Local Institution | Wichita | Kansas | — | — |
| Local Institution | Coeur d'Alene | Maryland | — | — |
| Local Institution | Cumberland | Maryland | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Duluth | Minnesota | — | — |
| Local Institution | Lincoln | Nebraska | — | — |
| Local Institution | New Brunswick | New Jersey | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | Albany | New York | — | — |
| Local Institution | Binghamton | New York | — | — |
| Local Institution | Mineola | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Syracuse | New York | — | — |
| Local Institution | The Bronx | New York | — | — |
| Local Institution | Wilmington | North Carolina | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Oklahoma City | Oklahoma | — | — |
| Local Institution | Duncansville | Pennsylvania | — | — |
| Local Institution | Norristown | Pennsylvania | — | — |
| Local Institution | Sellersville | Pennsylvania | — | — |
| Local Institution | Willow Grove | Pennsylvania | — | — |
| Local Institution | North Charleston | South Carolina | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Arlington | Virginia | — | — |
| Local Institution | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2011 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00048568 live on ClinicalTrials.gov.